Trak 1 Oncology Ventures SRL
Trak 1 Oncology Ventures reported total assets of €13.0m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Sep 2026).
By total assets for 2025, Trak 1 Oncology Ventures ranks among the 200 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Trak 1 Oncology Ventures shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Trak 1 Oncology Ventures's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Sep 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Trak 1 Oncology Ventures's financial analysis
- Solvency74.7%sector median: 54.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Trak 1 Oncology Ventures
Trak 1 Oncology Ventures's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0705.826.933
- VAT number
- BE0705826933
- Peppol
- Registered · 0208:0705826933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2018
- Registered office
- 2950 Kapellen
- Latest accounts
- 2025 · filed on 22 Sep 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Trak 1 Oncology Ventures (SRL) has been based in Kapellen since 2018, active in: other business support service activities n.e.c.. For 2025, it reports a net loss of 63,169 € and equity of €9.72m; its revenue is not published. Its solvency stands at 74.7%, above the median of its sector (54.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Trak 1 Oncology Ventures
Companies in the same business, of comparable size and area, outside its group.
- Transcity Invest Activities of holding companies Brussels · balance sheet €12.7m
- 3TEC Business and other management consultancy activities Bruges · balance sheet €15.7m
- Palenco Activities of holding companies Menen · balance sheet €14.3m
- Infraproject Activities of holding companies Oosterzele · balance sheet €9.56m
- Inside Investment Funds Activities of head offices Uccle · balance sheet €10.9m
- BriCapital Activities of holding companies Antwerp · balance sheet €53.2m
- AES Invest Activities of holding companies Waasmunster · balance sheet €25.3m
- JVM Invest Activities of holding companies Oudenaarde · balance sheet €31.9m
Frequently asked questions about Trak 1 Oncology Ventures
What is the revenue of Trak 1 Oncology Ventures?
Trak 1 Oncology Ventures files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Trak 1 Oncology Ventures?
In Belgium, the VAT number is the company number prefixed with BE: BE0705826933 for Trak 1 Oncology Ventures, if the company is VAT-registered. Its company number (CBE) is 0705.826.933.
Where is the registered office of Trak 1 Oncology Ventures?
According to the CBE register, the registered office of Trak 1 Oncology Ventures is in 2950 Kapellen.
What is the equity of Trak 1 Oncology Ventures?
At the close of the 2025 financial year, the equity of Trak 1 Oncology Ventures amounts to 9,717,450 €, a solvency of 74.7% of total assets.
Who manages Trak 1 Oncology Ventures?
The register lists 1 active mandates at Trak 1 Oncology Ventures. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Trak 1 Oncology Ventures within its sector?
By total assets for 2025, Trak 1 Oncology Ventures ranks among the 200 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Trak 1 Oncology Ventures
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →